SIGMAPHARM ARZNEIMITTEL GMBH – Trademark Portfolio

Entity Type: 16

SIGMAPHARM ARZNEIMITTEL GMBH holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ULTRASTOP and COLDAMARIS. The owner is based in VIENNA.

LEYSTRASSE 129

VIENNA 1201 , AT

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

SIGMAPHARM ARZNEIMITTEL GMBH's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does SIGMAPHARM ARZNEIMITTEL GMBH have?

SIGMAPHARM ARZNEIMITTEL GMBH has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does SIGMAPHARM ARZNEIMITTEL GMBH file in?

SIGMAPHARM ARZNEIMITTEL GMBH files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are SIGMAPHARM ARZNEIMITTEL GMBH's most well-known trademarks?

SIGMAPHARM ARZNEIMITTEL GMBH's registered trademark portfolio includes well-known marks such as ULTRASTOP and COLDAMARIS. These are among 2 currently registered trademarks in the portfolio.

What is SIGMAPHARM ARZNEIMITTEL GMBH's trademark registration success rate?

SIGMAPHARM ARZNEIMITTEL GMBH has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.